| scholarly article | Q13442814 |
| P2093 | author name string | Jon-Paul Bingham | |
| Zachary Bergeron | |||
| P2860 | cites work | Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia | Q83390312 |
| Wernerius inyoensis, an elusive new scorpion from the Inyo Mountains of California (Scorpiones, Vaejovidae) | Q21191975 | ||
| A quantitative description of membrane current and its application to conduction and excitation in nerve | Q22337072 | ||
| A potassium channel mutation in neonatal human epilepsy | Q24320244 | ||
| Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells | Q24562667 | ||
| Open structure of the Ca2+ gating ring in the high-conductance Ca2+-activated K+ channel | Q24605639 | ||
| ArachnoServer 2.0, an updated online resource for spider toxin sequences and structures | Q24615380 | ||
| ConoServer: updated content, knowledge, and discovery tools in the conopeptide database | Q24618928 | ||
| T3DB: a comprehensively annotated database of common toxins and their targets | Q24644620 | ||
| Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxins | Q24672213 | ||
| Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein | Q27620356 | ||
| Solution structure of BmKTX, a K+ blocker toxin from the Chinese scorpion Buthus Martensi | Q27621087 | ||
| NMR solution structure of butantoxin | Q27625026 | ||
| Synthesis, characterization, and application of cy-dye- and alexa-dye-labeled hongotoxin(1) analogues. The first high affinity fluorescence probes for voltage-gated K+ channels | Q27638983 | ||
| Disulfide folding pathways of cystine knot proteins. Tying the knot within the circular backbone of the cyclotides | Q27640159 | ||
| Solution structure of CnErg1 (Ergtoxin), a HERG specific scorpion toxin | Q27640753 | ||
| A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library | Q27658646 | ||
| Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus | Q27659136 | ||
| Total chemical synthesis and X-ray structure of kaliotoxin by racemic protein crystallography | Q27664730 | ||
| Use of toxins to study potassium channels | Q37380269 | ||
| The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy | Q37395286 | ||
| Design, synthesis, and functional expression of a gene for charybdotoxin, a peptide blocker of K+ channels | Q37424505 | ||
| Voltage-gated potassium channels as therapeutic targets | Q37464784 | ||
| Kv7 channels as targets for the treatment of pain | Q37482024 | ||
| Ralph F. Hirschmann award address 2009: Merger of organic chemistry with peptide diversity. | Q37708228 | ||
| Native chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins | Q37769178 | ||
| Cyclization of conotoxins to improve their biopharmaceutical properties. | Q37819305 | ||
| Engineering of conotoxins for the treatment of pain | Q37971973 | ||
| Cyclotides as a basis for drug design | Q37999102 | ||
| Discovery and applications of disulfide-rich cyclic peptides | Q38029088 | ||
| Drugs from slugs. Part II--conopeptide bioengineering | Q38051930 | ||
| Localization and mobility of omega-conotoxin-sensitive Ca2+ channels in hippocampal CA1 neurons | Q39274716 | ||
| Methylation of γ-carboxylated Glu (Gla) allows detection by liquid chromatography-mass spectrometry and the identification of Gla residues in the γ-glutamyl carboxylase. | Q39358254 | ||
| A facile, click chemistry-based approach to assembling fluorescent chemosensors for protein tyrosine kinases | Q39626836 | ||
| Conopeptide characterization and classifications: an analysis using ConoServer | Q39894009 | ||
| K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. | Q40482896 | ||
| A new strategy for the site-specific modification of proteins in vivo. | Q40643443 | ||
| Mapping the binding site of a human ether-a-go-go-related gene-specific peptide toxin (ErgTx) to the channel's outer vestibule | Q40657689 | ||
| Ultrasensitive pharmacological characterisation of the voltage-gated potassium channel K(V)1.3 studied by single-molecule fluorescence microscopy | Q40742307 | ||
| Generating a high affinity scorpion toxin receptor in KcsA-Kv1.3 chimeric potassium channels | Q40763711 | ||
| Solute accessibility to N epsilon-fluorescein isothiocyanate-lysine-23 cobra alpha-toxin bound to the acetylcholine receptor. A consideration of the effect of rotational diffusion and orientation constraints on fluorescence quenching | Q41140933 | ||
| Pharmacology of potassium channels. | Q41478126 | ||
| A new simple method which allows theoretical incorporation of radio-iodine into proteins and peptides without damage [proceedings] | Q41689790 | ||
| Comparison of prolactin levels in human semen and seminal plasma | Q41742684 | ||
| HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine | Q42554539 | ||
| Voltage-gated potassium channel Kv1.3 regulates GLUT4 trafficking to the plasma membrane via a Ca2+-dependent mechanism | Q42806277 | ||
| Modular strategy for the semisynthesis of a K+ channel: investigating interactions of the pore helix. | Q42931157 | ||
| Expressed protein ligation for the preparation of fusion proteins with cell penetrating peptides for endotoxin removal and intracellular delivery | Q43156396 | ||
| Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. | Q43228777 | ||
| A designed phenylalanyl-tRNA synthetase variant allows efficient in vivo incorporation of aryl ketone functionality into proteins | Q43992989 | ||
| Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States. | Q44169828 | ||
| Looking over toxin-K(+) channel interactions. Clues from the structural and functional characterization of α-KTx toxin Tc32, a Kv1.3 channel blocker | Q44229862 | ||
| A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1. | Q44287214 | ||
| Expression of porcine circovirus 2 ORF2 gene requires codon optimized E. coli cells | Q44314452 | ||
| A maurotoxin with constrained standard disulfide bridging: innovative strategy of chemical synthesis, pharmacology, and docking on K+ channels. | Q44463878 | ||
| Inhibition of the norepinephrine transporter by the venom peptide chi-MrIA. Site of action, Na+ dependence, and structure-activity relationship | Q44529216 | ||
| Site-specific incorporation of a redox-active amino acid into proteins | Q44670250 | ||
| A chemical toolkit for proteins--an expanded genetic code | Q44801045 | ||
| Interior surface modification of bacteriophage MS2. | Q44810692 | ||
| SCORPION2: a database for structure-function analysis of scorpion toxins | Q45087688 | ||
| Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation | Q45101337 | ||
| A novel short-chain peptide BmKX from the Chinese scorpion Buthus martensi Karsch, sequencing, gene cloning and structure determination | Q45246206 | ||
| BmP09, a "long chain" scorpion peptide blocker of BK channels | Q45254083 | ||
| Mapping the receptor site for charybdotoxin, a pore-blocking potassium channel inhibitor | Q45412468 | ||
| Synthesis, 3-D structure, and pharmacology of a reticulated chimeric peptide derived from maurotoxin and Tsk scorpion toxins | Q45713481 | ||
| A genetically encoded fluorescent amino acid. | Q46034866 | ||
| Leiurotoxin I (scyllatoxin), a peptide ligand for Ca2(+)-activated K+ channels. Chemical synthesis, radiolabeling, and receptor characterization | Q46190435 | ||
| Direct solid-phase synthesis and fluorescence labeling of large, monodisperse mannosylated dendrons in a peptide synthesizer | Q46666775 | ||
| Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells | Q36174761 | ||
| Potassium channels--multiplicity and challenges | Q36364450 | ||
| Three-dimensional structure of a protein from scorpion venom: a new structural class of neurotoxins | Q36414535 | ||
| Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins | Q36802602 | ||
| Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies | Q36943800 | ||
| Vascular large conductance calcium-activated potassium channels: functional role and therapeutic potential | Q36969112 | ||
| Kv7.1 (KCNQ1) properties and channelopathies. | Q37049827 | ||
| Animal toxins acting on voltage-gated potassium channels | Q37264924 | ||
| Kaliotoxin (1-37) shows structural differences with related potassium channel blockers | Q27729405 | ||
| 3D structure of kaliotoxin: is residue 34 a key for channel selectivity? | Q27742115 | ||
| Solution structure of TsKapa, a charybdotoxin-like scorpion toxin fromTityus serrulatus with high affinity for apamin-sensitive Ca2+-activated K+ channels | Q27747236 | ||
| Scorpion toxins specific for Na+-channels | Q28144635 | ||
| Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 | Q28145423 | ||
| A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy | Q28198095 | ||
| An expanded eukaryotic genetic code | Q28201981 | ||
| Role of disulfide bonds in folding and activity of leiurotoxin I: just two disulfides suffice | Q28201993 | ||
| Catalytic Activity and Chaperone Function of Human Protein-disulfide Isomerase Are Required for the Efficient Refolding of Proinsulin | Q28203834 | ||
| Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci | Q28237061 | ||
| Expanding the genetic code | Q28239578 | ||
| Antiretroviral prophylaxis for occupational exposure to HIV | Q28241415 | ||
| Synthetic peptides as tools to investigate the structure and pharmacology of potassium channel-acting short-chain scorpion toxins | Q28270835 | ||
| Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences | Q28271375 | ||
| Adding amino acids to the genetic repertoire | Q28279678 | ||
| Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease | Q28280077 | ||
| Use of chlorotoxin for targeting of primary brain tumors | Q28288404 | ||
| Scyllatoxin, a blocker of Ca(2+)-activated K+ channels: structure-function relationships and brain localization of the binding sites | Q28289825 | ||
| Discovery and characterization of a linear cyclotide from Viola odorata: implications for the processing of circular proteins | Q28298155 | ||
| The cyclotides and related macrocyclic peptides as scaffolds in drug design | Q28303989 | ||
| Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus | Q28323401 | ||
| Parameters affecting in vitro oxidation/folding of maurotoxin, a four-disulphide-bridged scorpion toxin | Q28349037 | ||
| Unique scorpion toxin with a putative ancestral fold provides insight into evolution of the inhibitor cystine knot motif | Q28743024 | ||
| 125IMargatoxin, an Extraordinarily High Affinity Ligand for Voltage-Gated Potassium Channels in Mammalian Brain | Q29014303 | ||
| Synthesis of proteins by native chemical ligation | Q29616750 | ||
| Nuclear magnetic resonance structural studies of a potassium channel-charybdotoxin complex. | Q30351969 | ||
| Synthesis of a biotin derivative of iberiotoxin: binding interactions with streptavidin and the BK Ca2+-activated K+ channel expressed in a human cell line | Q30483021 | ||
| Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences | Q30686326 | ||
| Structure-function study of a chlorotoxin-chimer and its activity on Kv1.3 channels | Q30759299 | ||
| Peptide thioester preparation by Fmoc solid phase peptide synthesis for use in native chemical ligation | Q30872871 | ||
| Novel structural class of four disulfide-bridged peptides from Tityus serrulatus venom | Q30887168 | ||
| Were arachnids the first to use combinatorial peptide libraries? | Q31138298 | ||
| Design and synthesis of a solid-phase fluorescent mass tag. | Q33225174 | ||
| ATDB: a uni-database platform for animal toxins | Q33302479 | ||
| Site directed mutants of Noxiustoxin reveal specific interactions with potassium channels | Q47851912 | ||
| Primary structure determination and cloning of the cDNA encoding toxin 4 of the scorpion Centruroides noxius Hoffmann | Q48128156 | ||
| Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels | Q48320626 | ||
| Noxiustoxin and leiurutoxin III, two homologous peptide toxins with binding properties to synaptosomal membrane K+ channels | Q48443326 | ||
| [125I]Iberiotoxin-D19Y/Y36F, the first selective, high specific activity radioligand for high-conductance calcium-activated potassium channels | Q48797903 | ||
| Chemical synthesis and characterization of maurotoxin, a short scorpion toxin with four disulfide bridges that acts on K+ channels. | Q48829352 | ||
| Agitoxin footprinting the shaker potassium channel pore | Q49020246 | ||
| Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals | Q49158543 | ||
| Localization and developmental expression of BK channels in mammalian cochlear hair cells. | Q50475244 | ||
| Solution structure of BTK-2, a novel hKv1.1 inhibiting scorpion toxin, from the eastern Indian scorpion Mesobuthus tamulus | Q50547885 | ||
| The first potassium channel toxin from the venom of the Iranian scorpion Odonthobuthus doriae | Q50643321 | ||
| Maurotoxin versus Pi1/HsTx1 scorpion toxins. Toward new insights in the understanding of their distinct disulfide bridge patterns. | Q50723911 | ||
| Mapping function to structure in a channel-blocking peptide: electrostatic mutants of charybdotoxin | Q52477856 | ||
| Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses | Q33508349 | ||
| MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity | Q33521610 | ||
| Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels | Q33572883 | ||
| Post-translationally modified neuropeptides from Conus venoms | Q33734580 | ||
| Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation | Q33896261 | ||
| An ERG channel inhibitor from the scorpion Buthus eupeus | Q33929814 | ||
| Structural basis for alpha-K toxin specificity for K+ channels revealed through the solution 1H NMR structures of two noxiustoxin-iberiotoxin chimeras | Q33954623 | ||
| K(+) channels as therapeutic drug targets | Q33960965 | ||
| ArachnoServer: a database of protein toxins from spiders | Q34010298 | ||
| Proteomic analysis provides insights on venom processing in Conus textile | Q34019951 | ||
| A new class of scorpion toxin binding sites related to an A-type K+ channel: pharmacological characterization and localization in rat brain | Q34084108 | ||
| State-specific mortality from sudden cardiac death--United States, 1999. | Q34118993 | ||
| Scorpion toxins as natural scaffolds for protein engineering | Q34123764 | ||
| A potent potassium channel blocker from Mesobuthus eupeus scorpion venom | Q34131423 | ||
| Disulfide bridges and blockage of Shaker B K(+)-channels by another butantoxin peptide purified from the Argentinean scorpion Tityus trivittatus. | Q34174746 | ||
| Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel | Q34185962 | ||
| Cone snail milked venom dynamics--a quantitative study of Conus purpurascens | Q34231068 | ||
| Selective blockage of voltage-dependent K+ channels by a novel scorpion toxin. | Q34253169 | ||
| CysView: protein classification based on cysteine pairing patterns. | Q34328889 | ||
| Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. | Q34358892 | ||
| The scorpion envenoming syndrome | Q34373831 | ||
| Synthesis of an iberiotoxin derivative by chemical ligation: a method for improved yields of cysteine-rich scorpion toxin peptides | Q34387133 | ||
| SCORPION, a molecular database of scorpion toxins | Q34402027 | ||
| hERG potassium channels and cardiac arrhythmia | Q34504394 | ||
| The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia | Q34534755 | ||
| Kv4 channels sensitive to BmTX3 in rat nervous system: autoradiographic analysis of their distribution during brain ontogenesis | Q34567397 | ||
| Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy | Q34917475 | ||
| Accelerated chemical synthesis of peptides and small proteins | Q34983403 | ||
| Subcellular protein localization by using a genetically encoded fluorescent amino acid. | Q35220252 | ||
| Unique interaction of scorpion toxins with the hERG channel | Q35770279 | ||
| Solution Structure of Kurtoxin: A Gating Modifier Selective for Cav3 Voltage-Gated Ca2+ Channels | Q35807764 | ||
| Novel forms of chemical protein diversity -- in nature and in the laboratory | Q35961241 | ||
| Non-clinical evaluation of ventricular repolarization (ICH S7B): results of an interim survey of international pharmaceutical companies | Q36173574 | ||
| Folding motifs induced and stabilized by distinct cystine frameworks | Q52565927 | ||
| Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction | Q53752825 | ||
| Engineering a uniquely reactive thiol into a cysteine-rich peptide | Q54637204 | ||
| A New Method of Forming Peptide Bonds | Q56815799 | ||
| Photocontrol of Tyrosine Phosphorylation in Mammalian Cells via Genetic Encoding of Photocaged Tyrosine | Q57431053 | ||
| Click-enabled heterotrifunctional template for sequential bioconjugations | Q58293314 | ||
| Scorpamins: the Toxic Proteins of Scorpion Venoms | Q58977133 | ||
| Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle | Q59079770 | ||
| Expanding the Genetic Code | Q60432486 | ||
| Characterization of γ-Carboxylated Tryptic Peptides by Collision-Induced Dissociation and Electron Transfer Dissociation Mass Spectrometry | Q61043260 | ||
| Reversed-phase high-performance liquid chromatography of protected peptide segments | Q61713974 | ||
| Structure-activity studies on scorpion toxins that block potassium channels | Q62900101 | ||
| Determination of the three-dimensional structure of iberiotoxin in solution by 1H nuclear magnetic resonance spectroscopy | Q67542555 | ||
| Solution synthesis of charybdotoxin (ChTX), A K+ channel blocker | Q67666889 | ||
| Synthesis and structural characterization of charybdotoxin, a potent peptidyl inhibitor of the high conductance Ca2(+)-activated K+ channel | Q67674609 | ||
| Three-dimensional structure of natural charybdotoxin in aqueous solution by 1H-NMR. Charybdotoxin possesses a structural motif found in other scorpion toxins | Q67683940 | ||
| Characterization of high affinity binding sites for charybdotoxin in sarcolemmal membranes from bovine aortic smooth muscle. Evidence for a direct association with the high conductance calcium-activated potassium channel | Q69117655 | ||
| Disulfide bonds of toxin II of the scorpion Androctonus australis Hector | Q69361401 | ||
| Synthetic peptides corresponding to the sequence of noxiustoxin indicate that the active site of this K+ channel blocker is located on its amino-terminal portion | Q69653582 | ||
| Changing the structural context of a functional beta-hairpin. Synthesis and characterization of a chimera containing the curaremimetic loop of a snake toxin in the scorpion alpha/beta scaffold | Q71142719 | ||
| Synthesis and biological evaluation of an iodinated iberiotoxin analogue, [mono-iodo-Tyr5, Phe36]-iberiotoxin | Q71689402 | ||
| Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release | Q72096278 | ||
| Purification and Some Properties of the Neurotoxins of Androctonus australis Hector* | Q72279548 | ||
| Synthesis and characterization of kaliotoxin. Is the 26-32 sequence essential for potassium channel recognition? | Q72639503 | ||
| Contribution of NMR spectroscopy to the study of structure-function relations of proteins and peptides | Q72752703 | ||
| Chemical synthesis and structure-activity relationships of Ts kappa, a novel scorpion toxin acting on apamin-sensitive SK channel | Q73187129 | ||
| Synthesis, 1H NMR structure, and activity of a three-disulfide-bridged maurotoxin analog designed to restore the consensus motif of scorpion toxins | Q73731329 | ||
| Consequence of the Removal of Evolutionary Conserved Disulfide Bridges on the Structure and Function of Charybdotoxin and Evidence That Particular Cysteine Spacings Govern Specific Disulfide Bond Formation | Q74229090 | ||
| Semisynthesis and folding of the potassium channel KcsA | Q74540695 | ||
| MASS SPECTROMETRY | Q76794298 | ||
| DETERMINATION OF AMINO ACID SEQUENCES IN OLIGOPEPTIDES BY MASS SPECTROMETRY. I. THE STRUCTURE OF FORTUITINE, AN ACYLNONAPEPTIDE METHYL ESTER | Q78394115 | ||
| The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia | Q79079948 | ||
| Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter | Q79299460 | ||
| Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages | Q79421562 | ||
| ConoServer, a database for conopeptide sequences and structures | Q80160913 | ||
| The solution structure of BmTx3B, a member of the scorpion toxin subfamily alpha-KTx 16 | Q81044044 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | scorpion | Q19125 |
| bioengineering | Q580689 | ||
| charybdotoxin | Q5087002 | ||
| potassium channel blocker | Q7234689 | ||
| scorpion venom | Q75034359 | ||
| P304 | page(s) | 1082-119 | |
| P577 | publication date | 2012-11-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Toxins | Q15724569 |
| P1476 | title | Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineering | |
| P478 | volume | 4 |
| Q39672702 | Activation of sodium channels by α-scorpion toxin, BmK NT1, produced neurotoxicity in cerebellar granule cells: an association with intracellular Ca2+ overloading. |
| Q35163762 | Androcin, a novel type of cysteine-rich venom peptide from Androctonus bicolor, induces akinesia and anxiety-like symptoms in mice |
| Q64076290 | Antibodies and venom peptides: new modalities for ion channels |
| Q33802553 | Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy. |
| Q64276032 | BmK AEP, an Anti-Epileptic Peptide Distinctly Affects the Gating of Brain Subtypes of Voltage-Gated Sodium Channels |
| Q26825574 | Centipede venoms and their components: resources for potential therapeutic applications |
| Q35785053 | Characterization of Kbot21 Reveals Novel Side Chain Interactions of Scorpion Toxins Inhibiting Voltage-Gated Potassium Channels. |
| Q50983541 | Chemical synthesis of La1 isolated from the venom of the scorpion Liocheles australasiae and determination of its disulfide bonding pattern |
| Q38595154 | Chlorotoxin: Structure, activity, and potential uses in cancer therapy |
| Q51494729 | Complexes of Peptide Blockers with Kv1.6 Pore Domain: Molecular Modeling and Studies with KcsA-Kv1.6 Channel. |
| Q41995788 | Crystallization and preliminary X-ray diffraction studies of La1 from Liocheles australasiae |
| Q26766001 | Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins |
| Q37670021 | Electrophysiological characterization of Ts6 and Ts7, K⁺ channel toxins isolated through an improved Tityus serrulatus venom purification procedure |
| Q90650797 | First Transcriptome Analysis of Iranian Scorpion, Mesobuthus Eupeus Venom Gland |
| Q38170857 | Immunosuppressive peptides and their therapeutic applications. |
| Q38247898 | Ion channel engineering: perspectives and strategies |
| Q64997056 | Isolation and Characterization of Insecticidal Toxins from the Venom of the North African Scorpion, Buthacus leptochelys. |
| Q37032053 | Modulation of BK Channel Function by Auxiliary Beta and Gamma Subunits |
| Q28540001 | Optimized scorpion polypeptide LMX: a pest control protein effective against rice leaf folder |
| Q36336806 | Partial purification and functional characterization of Ts19 Frag-I, a novel toxin from Tityus serrulatus scorpion venom |
| Q90669959 | Scorpion Venom-Toxins that Aid in Drug Development: A Review |
| Q42781479 | Scorpion toxins for the reversal of BoNT-induced paralysis |
| Q40421701 | Scorpion toxins prefer salt solutions |
| Q33871187 | Scorpion venom components that affect ion-channels function |
| Q58700388 | Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications |
| Q92150641 | Venoms of Iranian Scorpions (Arachnida, Scorpiones) and Their Potential for Drug Discovery |
Search more.